HIMCH
WST icon

Hartford Investment Management Co (HIMCO)’s West Pharmaceutical WST Stock Holding History

Hartford Investment Management Co (HIMCO)’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.4M Sell
3,898
-214
-5% -$65.4K 0.04% 337
2026
Q1 		$1.03M Sell
4,112
-49
-1% -$12.2K 0.03% 386
2025
Q4 		$1.14M Sell
4,161
-54
-1% -$14.8K 0.03% 370
2025
Q3 		$1.11M Sell
4,215
-116
-3% -$28.2K 0.03% 375
2025
Q2 		$948K Sell
4,331
-94
-2% -$20.1K 0.03% 398
2025
Q1 		$991K Sell
4,425
-46
-1% -$12.7K 0.03% 390
2024
Q4 		$1.46M Sell
4,471
-87
-2% -$27.4K 0.05% 322
2024
Q3 		$1.37M Sell
4,558
-110
-2% -$33.7K 0.05% 339
2024
Q2 		$1.54M Sell
4,668
-111
-2% -$39.2K 0.05% 307
2024
Q1 		$1.89M Sell
4,779
-205
-4% -$75.8K 0.07% 273
2023
Q4 		$1.75M Sell
4,984
-51
-1% -$18K 0.07% 281
2023
Q3 		$1.89M Sell
5,035
-168
-3% -$65K 0.08% 259
2023
Q2 		$1.99M Sell
5,203
-1,040
-17% -$372K 0.07% 266
2023
Q1 		$2.16M Buy
6,243
+900
+17% +$263K 0.07% 278
2022
Q4 		$1.26M Sell
5,343
-1,693
-24% -$401K 0.04% 368
2022
Q3 		$1.73M Sell
7,036
-43
-0.6% -$13.1K 0.06% 338
2022
Q2 		$2.14M Buy
7,079
+95
+1% +$30.9K 0.07% 295
2022
Q1 		$2.87M Sell
6,984
-535
-7% -$209K 0.07% 267
2021
Q4 		$3.53M Buy
7,519
+601
+9% +$259K 0.08% 250
2021
Q3 		$2.94M Sell
6,918
-845
-11% -$356K 0.08% 251
2021
Q2 		$2.79M Sell
7,763
-292
-4% -$96.5K 0.07% 286
2021
Q1 		$2.27M Sell
8,055
-367
-4% -$105K 0.06% 318
2020
Q4 		$2.39M Buy
8,422
+724
+9% +$203K 0.06% 291
2020
Q3 		$2.12M Sell
7,698
-274
-3% -$72.5K 0.07% 263
2020
Q2 		$1.81M Buy
+7,972
New +$1.57M 0.06% 290
2014
Q3 		– Sell
-7,497
Closed -$316K – 776
2014
Q2 		$316K Buy
7,497
+203
+3% +$8.69K 0.01% 650
2014
Q1 		$321K Buy
7,294
+155
+2% +$7.3K 0.01% 645
2013
Q4 		$350K Buy
+7,139
New +$334K 0.01% 647

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
BTCPP
Border to Coast Pensions Partnership Leeds, United Kingdom $6.78B AUM 31.6% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Hartford Investment Management Co (HIMCO)'s WST Position: Q2 2026 in Review

Hartford Investment Management Co (HIMCO) reduced its West Pharmaceutical (WST) stake by 5.2% in Q2 2026, selling an estimated $65.4K and leaving 3,898 shares worth $1.4M. The position accounts for 0.04% of the portfolio, ranked #337.

Hartford Investment Management Co (HIMCO) first reported a position in WST in Q4 2013 and has held it in 28 quarters since. The position peaked at $3.53M in Q4 2021. 426 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Hartford Investment Management Co (HIMCO) held 3,898 shares of West Pharmaceutical worth $1.4M as of Q2 2026.
  • Hartford Investment Management Co (HIMCO) sold 214 West Pharmaceutical shares in Q2 2026, an estimated $65.4K.
  • West Pharmaceutical made up 0.04% of Hartford Investment Management Co (HIMCO)'s portfolio in Q2 2026, its #337 holding.
  • Hartford Investment Management Co (HIMCO) first reported a position in West Pharmaceutical in Q4 2013 and has held it in 28 quarters since.
  • Hartford Investment Management Co (HIMCO)'s West Pharmaceutical position peaked at $3.53M in Q4 2021.
  • 426 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Hartford Investment Management Co (HIMCO)'s 13F filing for Q2 2026, filed 15 Jul 2026.